CD25 blockade in kidney transplant patients randomized to standard-dose or high-dose basiliximab with cyclosporine, or high-dose basiliximab in a calcineurin inhibitor-free regimen. [electronic resource]
Producer: 20161213Description: 184-95 p. digitalISSN:- 1432-2277
- Adult
- Aged
- Antibodies, Blocking -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Basiliximab
- Calcineurin Inhibitors -- therapeutic use
- Cyclosporine -- administration & dosage
- Female
- Graft Rejection
- Humans
- Immunosuppressive Agents -- administration & dosage
- Interleukin-2 Receptor alpha Subunit -- immunology
- Kidney Transplantation
- Male
- Middle Aged
- Prospective Studies
- Recombinant Fusion Proteins -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.